Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Hope Pharmaceuticals, Ltd., 120 Baker Street, London W1U 6TU, United Kingdom
Sodium Nitrite 30 mg/mL Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solutions for injection. The solution for injection is a clear and colourless sterile solution. |
Each vial contains 300 mg of sodium nitrite (30 mg/mL).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sodium nitrite |
Sodium nitrite is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning that is judged to be life-threatening. Sodium nitrite is thought to exert its therapeutic effect by reacting with hemoglobin to form methemoglobin, an oxidized form of hemoglobin incapable of oxygen transport but with high affinity for cyanide. |
| List of Excipients |
|---|
|
Water for injections |
Each carton of Sodium Nitrite Solution for Injection contains one 10 mL glass vial of sodium nitrite 30 mg/mL solution for injection (containing 300 mg of sodium nitrite).
Hope Pharmaceuticals, Ltd., 120 Baker Street, London W1U 6TU, United Kingdom
PL 42589/0001
19/06/2015
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
